Some authors argue that the correlation between symptoms and subtypes of SCA3 is going in disused [22], perhaps due to genetics that allowed the idea of distinct phenotypes and genotypes in a same disease [19]; or due to the inexorable progression of SCA3, that accumulate symptoms. This evidence concerns the gene ATXN3 and Machado-Joseph disease.